AgopY.BedikianMD

Clinical Trials

• Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma Start of enrollment: 1995 Nov 01

  Completed

  Phase 3

• Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy Start of enrollment: 2004 Dec 01

  Completed

  Phase 2

• Taxoprexin® Treatment for Advanced Eye Melanoma Start of enrollment: 2005 Oct 01

  Completed

  Phase 2

• Taxoprexin Treatment for Advanced Skin Melanoma Start of enrollment: 2005 Oct 01

  Completed

  Phase 2

• Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting Start of enrollment: 2006 Nov 01

  Completed

  Phase 1, Phase 2

• Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma Start of enrollment: 2005 Sep 01

  Completed

  Phase 1

• Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver Start of enrollment: 2009 Feb 01

  Completed

  Phase 1

• Study of Weekly LOC-paclitaxel Injection for Melanoma Start of enrollment: 2009 Dec 01

  Terminated

  Phase 1

• Phase II Study of Tesetaxel in Metastatic Melanoma Start of enrollment: 2010 Feb 01

  Completed

  Phase 2

• A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma Start of enrollment: 2010 Feb 03

  Terminated

  Phase 1

• Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH Start of enrollment: 2010 Feb 01

  Unknown status

  Phase 2

• Open-Label Study of TPI 287 for Patients With Metastatic Melanoma Start of enrollment: 2013 Sep 01

  Withdrawn

  Phase 1, Phase 2

• IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma Start of enrollment: 2013 Feb 01

  Terminated

  Phase 1

• Join now to see all